<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.138780.2</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Case Report</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Case Report: Sebaceous carcinoma of the eyelid</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 2; peer review: 1 approved with reservations, 1 not approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Bhawani</surname>
                        <given-names>Jayashree</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-8552-0678</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Shukla</surname>
                        <given-names>Samarth</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Acharya</surname>
                        <given-names>Sourya</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Vagha</surname>
                        <given-names>Sunita</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Jagtap</surname>
                        <given-names>Miheer</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Department of Pathology, Jawaharlal Nehru Medical College, Sawangi(Meghe), Wardha, Maharashtra, 442001, India</aff>
                <aff id="a2">
                    <label>2</label>Department of General Medicine, Jawaharlal Nehru Medical College, Sawangi(Meghe), Wardha, Maharashtra, 442001, India</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:jayashree1993rey@gmail.com">jayashree1993rey@gmail.com</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>12</day>
                <month>6</month>
                <year>2024</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2023</year>
            </pub-date>
            <volume>12</volume>
            <elocation-id>1563</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>11</day>
                    <month>6</month>
                    <year>2024</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Bhawani J et al.</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/12-1563/pdf"/>
            <abstract>
                <p>Sebaceous carcinoma is an extremely rare malignant disease and it is more aggressive when it occurs in the eyelids and orbit. It can mimic several benign lesions, resulting in diagnostic delay. We present a case of sebaceous carcinoma in a 50-year-old male who presented with complaints of swelling of the upper eyelid, which was followed by appearance of an ulcerative growth over the eyelid. Magnetic resonance imaging (MRI) reports showed an ulcerated mass in the left periorbital and orbital region appearing heterogeneously hyperintense. Fine needle aspiration cytology (FNAC) showed malignant epithelial differentiation which was followed by exenteration of the eyeball. Histopathology showed the rare diagnosis of sebaceous carcinoma. The disease has a poor prognosis as the entity is associated with increased morbidity and if not detected early it can metastasize to other organs which may be fatal sometimes.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Sebaceous carcinoma</kwd>
                <kwd>Muir- Torre syndrome</kwd>
                <kwd>eyelid cancer</kwd>
            </kwd-group>
            <funding-group>
                <funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement>
            </funding-group>
        </article-meta>
        <notes>
            <sec sec-type="version-changes">
                <label>Revised</label>
                <title>Amendments from Version 1</title>
                <p>We have added certain details suggested by the reviewer for better understanding of the disease.</p>
            </sec>
        </notes>
    </front>
    <body>
        <sec id="sec1" sec-type="intro">
            <title>Introduction</title>
            <p>Sebaceous carcinoma originates from cutaneous sebaceous glands, gland of Zeis or the Meibomian glands.
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>
                </sup> It is more commonly found in the Asian population.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> It has a syndromic association with Muir-Torre syndrome, with hereditary nonpolyposis colorectal cancer syndrome.
                <sup>
                    <xref ref-type="bibr" rid="ref3">3</xref>
                </sup> It can occur secondary to radiation therapy for retinoblastoma.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup> It clinically mimics some benign conditions such as blepharitis, chalazion and sometimes basal cell carcinoma or squamous cell carcinoma which causes difficulty in diagnosing the disease.
                <sup>
                    <xref ref-type="bibr" rid="ref5">5</xref>
                </sup> It is very essential to diagnose this fatal disease due to its potential of metastasis and local invasion. Early diagnosis can prevent patient&#x2019;s vision and may increase survival. Here, we report a case of sebaceous carcinoma of the upper eyelid on histopathology of orbital exenteration specimen.</p>
            <sec id="sec2">
                <title>Patient information</title>
                <p>A 50-year-old male, farmer by occupation, presented with an 8-month history of an ulcerated growth over the left eye. The patient stated that the lesion started as a pea sized cystic swelling which gradually increased in size. He also gave a history of pain and maggot infestation in the same eye for which he took symptomatic treatment. Condition of patient deteriorated further, so he came to the tertiary care centre for further management.</p>
            </sec>
            <sec id="sec3">
                <title>Clinical findings</title>
                <p>Routine investigations were performed, on ocular examination no light perception was present. Slit lamp examination of the left showed a mass of 6.3 &#x00d7; 3 &#x00d7; 1.5 cm with ulcerated appearance. Eyelashes were spared. The eyeball appeared as degenerated and distorted. On general examination no lymphadenopathy and organomegaly was noted.</p>
            </sec>
            <sec id="sec4">
                <title>Diagnostic assessment</title>
                <p>MRI (Magnetic resonance imaging) reports showed an ulcerated mass in the left periorbital and orbital region appearing heterogeneously hyperintense on T2 and hypointense on T1 which was involving the left orbital group, adjacent intraorbital optic nerve and extraocular muscles.</p>
                <p>Fine needle aspiration cytology (FNAC) was performed which showed polymorphs, lymphocytes and islands of tumor cells. These tumor cells appeared large in size, oval in shape and were arranged in groups. These cells had hyperchromatic nuclei. Cells also showed malignant epithelial differentiation.</p>
            </sec>
            <sec id="sec5">
                <title>Therapeutic interventions</title>
                <p>One day prior to surgery general physical examination and orbital examination was done. Patient was considered fit for the intervention. A surgical intervention named intraoperative frozen section was performed from the lesion and diagnosis suggestive of carcinoma either from sebaceous or squamous origin was made. After that, left eye exenteration was done.</p>
            </sec>
            <sec id="sec6">
                <title>The follow up and outcomes</title>
                <p>The resected orbital exenteration specimen [
                    <xref ref-type="fig" rid="f1">Figure 1</xref>] was sent to histopathology. Specimen measured 6.2 &#x00d7; 6 &#x00d7; 3.5 cm. A tumor mass involving the upper eyelid extending from the medial margin measuring 5 &#x00d7; 2 &#x00d7; 1.5 cm was identified.</p>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <title>The resected orbital exenteration specimen.</title>
                    </caption>
                    <graphic id="gr1" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/167808/cd0f2d02-4505-4527-9ad9-b1680901318e_figure1.gif"/>
                </fig>
                <p>Microscopy showed pigmented lining epithelium. A scanner view of the section [
                    <xref ref-type="fig" rid="f2">Figure 2</xref>] also showed tumor cells arranged in lobules and sheets at places. High power view i.e. 40&#x00d7; showed sebaceous differentiation [
                    <xref ref-type="fig" rid="f3">Figure 3</xref>], individual tumor cells, which were polygonal in shape with scant, multivacuolated cytoplasm, it also showed round to oval, enlarged pleomorphic nuclei with 1&#x2013;2 prominent nucleoli [
                    <xref ref-type="fig" rid="f4">Figure 4</xref>]. Deeper tissues showed fibro collagenous tissue, necrotic hemorrhagic tissue and infiltration by malignant cells.</p>
                <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                    <label>Figure 2. </label>
                    <caption>
                        <title>10&#x00d7; magnification showing tumor cells arranged in lobules and sheets.</title>
                    </caption>
                    <graphic id="gr2" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/167808/cd0f2d02-4505-4527-9ad9-b1680901318e_figure2.gif"/>
                </fig>
                <fig fig-type="figure" id="f3" orientation="portrait" position="float">
                    <label>Figure 3. </label>
                    <caption>
                        <title>40&#x00d7; magnification showing sebaceous differentiation.</title>
                    </caption>
                    <graphic id="gr3" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/167808/cd0f2d02-4505-4527-9ad9-b1680901318e_figure3.gif"/>
                </fig>
                <fig fig-type="figure" id="f4" orientation="portrait" position="float">
                    <label>Figure 4. </label>
                    <caption>
                        <title>40&#x00d7; magnification showing individual tumor cells, polygonal in shape with scant, multivacuolated cytoplasm.</title>
                    </caption>
                    <graphic id="gr4" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/167808/cd0f2d02-4505-4527-9ad9-b1680901318e_figure4.gif"/>
                </fig>
            </sec>
        </sec>
        <sec id="sec7" sec-type="discussion">
            <title>Discussion</title>
            <p>Sebaceous carcinoma is a great masquerader.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup> Although sebaceous carcinoma has great tendency to arise in the ocular region, especially in the eyelids, it does occur in extraocular regions such as parotid. It accounts for 1 to 3% of malignant orbital tumors.
                <sup>
                    <xref ref-type="bibr" rid="ref7">7</xref>
                </sup> Among the reported malignancies of eyelid tumors it is the third most common malignancy.
                <sup>
                    <xref ref-type="bibr" rid="ref8">8</xref>
                </sup> It has a female predominance.
                <sup>
                    <xref ref-type="bibr" rid="ref9">9</xref>
                </sup> The upper eyelid is affected more than the lower lid due to the abundance of meibomian glands.
                <sup>
                    <xref ref-type="bibr" rid="ref10">10</xref>
                </sup> Periocular sebaceous carcinoma can clinically mimic a range of conditions and are misdiagnosed as basal cell carcinoma or squamous cell carcinoma.
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup>
            </p>
            <p>The most common presentation of sebaceous carcinoma in the eyelid is as round highly cellular nests of poorly differentiated tumor cells. Sometimes better differentiated cells with vacuolated cytoplasm are identified.
                <sup>
                    <xref ref-type="bibr" rid="ref12">12</xref>
                </sup>
            </p>
            <p>Many studies have shown that sebaceous carcinoma of the eyelid has a poor prognosis and if there is an orbital or vascular invasion present prognosis further worsens.
                <sup>
                    <xref ref-type="bibr" rid="ref13">13</xref>
                </sup>
            </p>
            <p>The treatment of choice for sebaceous carcinoma is surgery, with complete excision verified by negative margins.
                <sup>
                    <xref ref-type="bibr" rid="ref14">14</xref>
                </sup>
            </p>
        </sec>
        <sec id="sec8" sec-type="conclusions">
            <title>Conclusions</title>
            <p>Sebaceous carcinoma of the eyelid is a rare entity, but might be difficult to diagnose because of its ability to masquerade as the periocular lesions. However, accurate and prompt diagnosis is crucial for planning further management of the disease and prevention of any complications such as loss of vision, metastasis to other organs etc, therefore tissue diagnosis is the gold standard method and it can be aided by a panel of immunohistochemistry stains.</p>
        </sec>
        <sec id="sec9">
            <title>Case report consent</title>
            <p>Written informed consent for publication of their clinical details and clinical images was obtained from the patients.</p>
        </sec>
        <sec id="sec10">
            <title>Author&#x2019;s contributions</title>
            <p>Jayashree Bhawani: drafting the case report and overview of patient management. Dr. Samarth Shukla: Reporting of the excised specimen sent for histopathological investigation and giving the suitable diagnosis. All the authors read and approved the final version of this manuscript.</p>
        </sec>
    </body>
    <back>
        <sec id="sec13" sec-type="data-availability">
            <title>Data availability</title>
            <p>All data underlying the results are available as part of the article and no additional source data are required.</p>
        </sec>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Rao</surname>
                            <given-names>NA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hidayat</surname>
                            <given-names>LC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>McLean</surname>
                            <given-names>LC</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data.</article-title>
                    <source>

                        <italic toggle="yes">Hum. Pathol.</italic>
</source>
                    <year>1982 Feb 1</year>;<volume>13</volume>(<issue>2</issue>):<fpage>113</fpage>&#x2013;<lpage>122</lpage>.
                    <pub-id pub-id-type="pmid">7076199</pub-id>
                    <pub-id pub-id-type="doi">10.1016/S0046-8177(82)80115-9</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Wu</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rajak</surname>
                            <given-names>SN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chiang</surname>
                            <given-names>CJ</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Epidemiology of cutaneous sebaceous carcinoma.</article-title>
                    <source>

                        <italic toggle="yes">Australas. J. Dermatol.</italic>
</source>
                    <year>2021 Feb</year>;<volume>62</volume>(<issue>1</issue>):<fpage>57</fpage>&#x2013;<lpage>59</lpage>.
                    <pub-id pub-id-type="pmid">32632921</pub-id>
                    <pub-id pub-id-type="doi">10.1111/ajd.13387</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>John</surname>
                            <given-names>AM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Schwartz</surname>
                            <given-names>RA</given-names>
                        </name>
</person-group>:
                    <article-title>Muir-Torre syndrome (MTS): an update and approach to diagnosis and management.</article-title>
                    <source>

                        <italic toggle="yes">J. Am. Acad. Dermatol.</italic>
</source>
                    <year>2016 Mar 1</year>;<volume>74</volume>(<issue>3</issue>):<fpage>558</fpage>&#x2013;<lpage>566</lpage>.
                    <pub-id pub-id-type="pmid">26892655</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jaad.2015.09.074</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kaliki</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ayyar</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Dave</surname>
                            <given-names>TV</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.</article-title>
                    <source>

                        <italic toggle="yes">Eye (Lond.).</italic>
</source>
                    <year>2015 Jul</year>;<volume>29</volume>(<issue>7</issue>):<fpage>958</fpage>&#x2013;<lpage>963</lpage>.
                    <pub-id pub-id-type="pmid">25998946</pub-id>
                    <pub-id pub-id-type="doi">10.1038/eye.2015.79</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4506352</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kass</surname>
                            <given-names>LG</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hornblass</surname>
                            <given-names>A</given-names>
                        </name>
</person-group>:
                    <article-title>Sebaceous carcinoma of the ocular adnexa.</article-title>
                    <source>

                        <italic toggle="yes">Surv. Ophthalmol.</italic>
</source>
                    <year>1989 May 1</year>;<volume>33</volume>(<issue>6</issue>):<fpage>477</fpage>&#x2013;<lpage>490</lpage>.
                    <pub-id pub-id-type="doi">10.1016/0039-6257(89)90049-0</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Buitrago</surname>
                            <given-names>W</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Joseph</surname>
                            <given-names>AK</given-names>
                        </name>
</person-group>:
                    <article-title>Sebaceous carcinoma: the great masquerader: emerging concepts in diagnosis and treatment.</article-title>
                    <source>

                        <italic toggle="yes">Dermatol. Ther.</italic>
</source>
                    <year>2008 Nov</year>;<volume>21</volume>(<issue>6</issue>):<fpage>459</fpage>&#x2013;<lpage>466</lpage>.
                    <pub-id pub-id-type="pmid">19076624</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1529-8019.2008.00247.x</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Shields</surname>
                            <given-names>JA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Demirci</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Marr</surname>
                            <given-names>BP</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Sebaceous carcinoma of the ocular region: a review.</article-title>
                    <source>

                        <italic toggle="yes">Surv. Ophthalmol.</italic>
</source>
                    <year>2005 Mar 1</year>;<volume>50</volume>(<issue>2</issue>):<fpage>103</fpage>&#x2013;<lpage>122</lpage>.
                    <pub-id pub-id-type="pmid">15749305</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.survophthal.2004.12.008</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Slutsky</surname>
                            <given-names>JB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jones</surname>
                            <given-names>EC</given-names>
                        </name>
</person-group>:
                    <article-title>Periocular cutaneous malignancies: a review of the literature.</article-title>
                    <source>

                        <italic toggle="yes">Dermatol. Surg.</italic>
</source>
                    <year>2012 Apr</year>;<volume>38</volume>(<issue>4</issue>):<fpage>552</fpage>&#x2013;<lpage>569</lpage>.
                    <pub-id pub-id-type="doi">10.1111/j.1524-4725.2012.02367.x</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Yu</surname>
                            <given-names>SS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zhao</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zhao</surname>
                            <given-names>H</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A retrospective study of 2228 cases with eyelid tumors.</article-title>
                    <source>

                        <italic toggle="yes">Int. J. Ophthalmol.</italic>
</source>
                    <year>2018</year>;<volume>11</volume>(<issue>11</issue>):<fpage>1835</fpage>&#x2013;<lpage>1841</lpage>.
                    <pub-id pub-id-type="pmid">30450316</pub-id>
                    <pub-id pub-id-type="doi">10.18240/ijo.2018.11.16</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Shields</surname>
                            <given-names>JA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Demirci</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Marr</surname>
                            <given-names>BP</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Sebaceous carcinoma of the eyelids: personal experience with 60 cases.</article-title>
                    <source>

                        <italic toggle="yes">Ophthalmology.</italic>
</source>
                    <year>2004 Dec 1</year>;<volume>111</volume>(<issue>12</issue>):<fpage>2151</fpage>&#x2013;<lpage>2157</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.ophtha.2004.07.031</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sinard</surname>
                            <given-names>JH</given-names>
                        </name>
</person-group>:
                    <article-title>Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.</article-title>
                    <source>

                        <italic toggle="yes">Arch. Ophthalmol.</italic>
</source>
                    <year>1999 Jun 1</year>;<volume>117</volume>(<issue>6</issue>):<fpage>776</fpage>&#x2013;<lpage>783</lpage>.
                    <pub-id pub-id-type="pmid">10369589</pub-id>
                    <pub-id pub-id-type="doi">10.1001/archopht.117.6.776</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sadeghi</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pitman</surname>
                            <given-names>MB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Weir</surname>
                            <given-names>MM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Cytologic features of metastatic sebaceous carcinoma: report of two cases with comparison to three cases of basal cell carcinoma.</article-title>
                    <source>

                        <italic toggle="yes">Diagn. Cytopathol.</italic>
</source>
                    <year>1999 Nov</year>;<volume>21</volume>(<issue>5</issue>):<fpage>340</fpage>&#x2013;<lpage>345</lpage>.
                    <pub-id pub-id-type="pmid">10527482</pub-id>
                    <pub-id pub-id-type="doi">10.1002/(SICI)1097-0339(199911)21:5&lt;340::AID-DC9&gt;3.0.CO;2-C</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hoffman</surname>
                            <given-names>GR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jefferson</surname>
                            <given-names>ND</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Reid</surname>
                            <given-names>CB</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Orbital exenteration to manage infiltrative sinonasal, orbital adnexal, and cutaneous malignancies provide acceptable survival outcomes: an institutional review, literature review, and meta-analysis.</article-title>
                    <source>

                        <italic toggle="yes">J. Oral Maxillofac. Surg.</italic>
</source>
                    <year>2016 Mar 1</year>;<volume>74</volume>(<issue>3</issue>):<fpage>631</fpage>&#x2013;<lpage>643</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.joms.2015.09.019</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Gulleth</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Goldberg</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Silverman</surname>
                            <given-names>RP</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>What is the best surgical margin for a Basal cell carcinoma: a meta-analysis of the literature.</article-title>
                    <source>

                        <italic toggle="yes">Plast. Reconstr. Surg.</italic>
</source>
                    <year>2010 Oct 1</year>;<volume>126</volume>(<issue>4</issue>):<fpage>1222</fpage>&#x2013;<lpage>1231</lpage>.
                    <pub-id pub-id-type="doi">10.1097/PRS.0b013e3181ea450d</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report320812">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.167808.r320812</article-id>
            <title-group>
                <article-title>Reviewer response for version 2</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Vempuluru</surname>
                        <given-names>Vijitha S</given-names>
                    </name>
                    <xref ref-type="aff" rid="r320812a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-1859-6629</uri>
                </contrib>
                <aff id="r320812a1">
                    <label>1</label>LV Prasad Eye Institute, Hyderabad, Telangana, India</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>12</day>
                <month>9</month>
                <year>2024</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Vempuluru VS</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport320812" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.138780.2"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>reject</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The authors report a case of eyelid sebaceous carcinoma with orbital extension which was managed with orbital exenteration.</p>
            <p> The pathology images are good. There are no external photographs or MRI images. There is no mention of systemic metastatic workup or further follow-up.</p>
            <p> Overall this is not a rare diagnosis or a rare presentation of a common disease.</p>
            <p>Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?</p>
            <p>No</p>
            <p>Is the case presented with sufficient detail to be useful for other practitioners?</p>
            <p>No</p>
            <p>Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?</p>
            <p>Partly</p>
            <p>Is the background of the case&#x2019;s history and progression described in sufficient detail?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Ocular oncology</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.</p>
        </body>
        <back>
            <ref-list>
                <title>References</title>
                <ref id="rep-ref-320812-1">
                    <label>1</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Eyelid/Periocular Sebaceous Gland Carcinoma in 500 Eyes: Analysis based on 8th Edition American Joint Cancer Committee Classification.</article-title>
                        <source>
                            <italic>Am J Ophthalmol</italic>
                        </source>.<year>2024</year>;
                        <elocation-id>10.1016/j.ajo.2024.07.036</elocation-id>
                        <pub-id pub-id-type="pmid">39103137</pub-id>
                        <pub-id pub-id-type="doi">10.1016/j.ajo.2024.07.036</pub-id>
                    </mixed-citation>
                </ref>
            </ref-list>
        </back>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report263242">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.152008.r263242</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Ma</surname>
                        <given-names>Jianmin</given-names>
                    </name>
                    <xref ref-type="aff" rid="r263242a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r263242a1">
                    <label>1</label>Capital Medical University, Beijing, China</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>30</day>
                <month>5</month>
                <year>2024</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Ma J</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport263242" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.138780.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Overall Assessment</p>
            <p> The case report on sebaceous carcinoma is comprehensive and detailed, providing valuable insights into the presentation, diagnostic process, therapeutic interventions, and outcomes of this rare condition. However, several areas require attention to improve clarity, accuracy, and readability. The following are my detailed comments and suggestions:</p>
            <p> </p>
            <p> Abstract</p>
            <p> Content and Clarity: The abstract is clear and summarizes the case effectively. Consider adding a sentence about the prognosis or significance of prompt diagnosis to underscore the clinical importance.</p>
            <p> Keywords: The keywords are appropriate but could include "orbital exenteration" and "histopathology" for better indexing.</p>
            <p> </p>
            <p> Introduction</p>
            <p> Background Information: The introduction provides a good overview. Consider expanding on the clinical significance of sebaceous carcinoma and its diagnostic challenges.</p>
            <p> Patient Information</p>
            <p> Patient History: The patient history is well-detailed. Consider specifying the duration between the onset of symptoms and seeking medical advice to highlight any potential delays in diagnosis.</p>
            <p> </p>
            <p> Clinical Findings</p>
            <p> Details and Clarity: The clinical findings section is clear. Consider specifying whether any other systemic examinations were performed, given the potential for metastasis in malignant conditions.</p>
            <p> </p>
            <p> Diagnostic Assessment</p>
            <p> Diagnostic Methods: The MRI and FNAC findings are described well. Ensure technical terms like "heterogeneously hyperintense" are explained or referenced for clarity.</p>
            <p> Figures: Ensure all figures are of high quality and properly referenced in the text. Consider providing a brief description of what each figure illustrates within the text.</p>
            <p> Therapeutic Interventions</p>
            <p> </p>
            <p> Surgical Details: The description of the surgical intervention is clear. Include any preoperative considerations or complications, if applicable.</p>
            <p> </p>
            <p> Follow-up and Outcomes</p>
            <p> Specimen Analysis: The analysis of the resected specimen is detailed. Ensure all histopathological findings are clearly described, and consider including a brief discussion on the typical histopathological features of sebaceous carcinoma.</p>
            <p> </p>
            <p> Discussion</p>
            <p> Literature Review: The discussion provides a good review of the literature. Consider comparing this case to similar reported cases to highlight unique aspects or common patterns.</p>
            <p> Prognosis and Management: Expand on the prognosis and management strategies, including potential follow-up treatments or monitoring.</p>
            <p> </p>
            <p> Conclusions</p>
            <p> Summary: The conclusions are concise. Emphasize the importance of early diagnosis and potential outcomes with timely intervention.</p>
            <p> </p>
            <p> References</p>
            <p> Formatting: Ensure all references are formatted according to the journal's guidelines.</p>
            <p> Completeness: Verify that all references cited in the text are included in the reference list and are correctly formatted.</p>
            <p> Specific Suggestions for Improvement</p>
            <p> Technical Terms: Define or reference all technical terms and acronyms (e.g., FNAC, MRI) upon their first use in the text.</p>
            <p> Grammar and Style: Review the manuscript for grammatical errors and ensure consistent scientific style.</p>
            <p> Figures and Tables: Ensure all figures and tables are clear, well-labeled, and properly referenced in the text.</p>
            <p> Flow and Structure: Ensure smooth transitions between sections for better readability.</p>
            <p> </p>
            <p> Suggested Citation</p>
            <p> To strengthen the discussion on sebaceous carcinoma of the eyelid, it would be beneficial to cite the following paper, which provides a comprehensive review of sebaceous gland hyperplasia and related conditions:</p>
            <p> Ma M. et. al., 2024 (Ref 1)</p>
            <p> This paper discusses the differential diagnosis and management strategies for sebaceous gland lesions, which can provide a comparative perspective to your case report on sebaceous carcinoma.</p>
            <p> </p>
            <p> Conclusion</p>
            <p> This case report provides valuable insights into sebaceous carcinoma of the eyelid. With the above revisions, it will significantly enhance its clarity, impact, and contribution to the field.</p>
            <p> I recommend a revision to address the points mentioned above.</p>
            <p>Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?</p>
            <p>Yes</p>
            <p>Is the case presented with sufficient detail to be useful for other practitioners?</p>
            <p>Partly</p>
            <p>Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?</p>
            <p>Yes</p>
            <p>Is the background of the case&#x2019;s history and progression described in sufficient detail?</p>
            <p>No</p>
            <p>Reviewer Expertise:</p>
            <p>Orbital Diseases</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <back>
            <ref-list>
                <title>References</title>
                <ref id="rep-ref-263242-1">
                    <label>1</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Sebaceous hyperplasia of the eyelid: A comprehensive case report and literature review</article-title>.
                        <source>
                            <italic>Heliyon</italic>
                        </source>.<year>2024</year>;<volume>10</volume>(<issue>7</issue>) :
                        <elocation-id>10.1016/j.heliyon.2024.e28511</elocation-id>
                        <pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e28511</pub-id>
                    </mixed-citation>
                </ref>
            </ref-list>
        </back>
        <sub-article article-type="response" id="comment11748-263242">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Bhawani</surname>
                            <given-names>Jayashree</given-names>
                        </name>
                        <aff>Pathology, Jawaharlal Nehru medical college, Sawangi (Meghe), Sawangi, Wardha, Maharashtra, India</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interest</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>10</day>
                    <month>6</month>
                    <year>2024</year>
                </pub-date>
            </front-stub>
            <body>
                <p>Thank you for the suggestions Sir/Maam</p>
                <p> I am including your suggestions in the new version of the case report.</p>
            </body>
        </sub-article>
    </sub-article>
</article>
